RHRizqiya Astri Hapsari

Rizqiya Astri Hapsari

*This is an algorithmically generated author record based on publicly available information.

Rizqiya Astri Hapsari has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Alfi Khatib

    Department of Pharmaceutical Chemistry, Kulliyyah of Pharmacy, International Islamic University Malaysia, Kuantan, Malaysia

    1 shared publication
  • Anastasia Fitria Devi

    Research Center for Chemistry, National Research and Innovation Agency (BRIN) Republic of Indonesia, Kawasan Puspiptek, Tangerang Selatan 15314, Indonesia

    1 shared publication
  • Berna Elya

    Faculty of Pharmacy, Universitas Indonesia, Depok 16424, West Java, Indonesia

    1 shared publication
  • Husniati Husniati

    Department of Pharmacognosy and Phytochemistry, Faculty of Pharmacy, Universitas Indonesia, Depok 16424, Indonesia

    1 shared publication
  • Muhammad Hanafi

    3) Research Center for Pharmaceutical Ingredients and Traditional Medicine, National Research and Innovation Agency (BRIN), Serpong. 15314, Indonesia. 4) Department of Phytochemistry, Faculty of Pharmacy, Pancasila University, South Jakarta, 12640

    1 shared publication
  • Nina Artanti

    Research Center for Chemistry, National Research and Innovation Agency (BRIN), Tangerang Selatan 15314, Banten, Indonesia

    1 shared publication

Latest Publications

  • Open Access

    Identification of Potential Antioxidant and Antidiabetic α-Glucosidase Inhibitors from Pometia pinnata Through In Vitro, Metabolite Profiling, and Molecular Docking

    by Husniati Husniati, Berna Elya, Muhammad Hanafi, Alfi Khatib, Winni Nur Auli, Nina Artanti, Anastasia Fitria Devi, Teni Ernawati, Rizqiya Astri Hapsari

    Oxidative stress induced by reactive oxygen species is critical in the progressing of type 2 diabetes mellitus. Thus, early intervention using plant-derived secondary metabolites with antioxidant and α-glucosidase inhibitory (AGI) activities is essential for adequate glycemic control. Pometia pinnata has demonstrated antidiabetic potential, though scientific evidence remains limited. This study aimed to determine the in vitro antioxidant and AGI activities of P. pinnata extracts (fruit peel, root bark, and stem bark). Metabolites from selected stem bark extracts were identified via LC-HRMS and further validated through molecular docking. Sequential maceration using n-hexane, ethyl acetate, methanol, and water was employed to obtain extracts. Ethyl acetate extracts of stem and root bark showed significantly higher total phenolic and flavonoid contents with higher antioxidant activity than other solvent extracts. The stem bark extract yielded the highest compound content (2.74%) and AGI activity (62.78 ± 0.85% inhibition at 15 μg/mL), outperforming the standard drug acarbose (14.66% at the same dose). LC-HRMS profiling of the stem bark extract identified 26 metabolites, with cianidanol exhibiting the strongest binding affinity (ΔG°bind = –7.63 kcal/mol) in molecular docking, surpassing acarbose (–2.51 kcal/mol). These findings confirm the presence of bioactive compounds in P. pinnata that contribute to α-glucosidase inhibition and are correlated with antioxidant capacity.